Watch it here: To view or add a comment, sign in BRIEF REPORT A preliminary model to tailor Osilodrostat in patients with ACTH dependent Cushings syndrome EJE Volume 193, Issue 4, October 2025 Open access article Authors Ccilia Piazzola , Frederic Castinetti , Katharina von Fabeck , Nicolas Simon Abstract Over the past 10 years, osilodrostat has become one of the most commonly used steroidogenesis inhibitors in patients with Cushing's syndrome
U IM NI BT: Cng Ngh Liposomal c Quyn: m bo sinh kh dng cao v tng cng kh nng hp th Glutathione vo c th, gip hot cht pht huy hiu qu ti a
Amgen also announced it is scrapping plans for an obesity pill, another area of the market that will be competitive, as Lilly, Novo, and Pfizer (PFE) are all working on options
ZhangTYiXLiJZhengXXuHLiaoDet al
Perhaps the most exciting area of joint research involves the use of polyphenols like Resveratrol to protect the genetic health of chondrocytes